|Other Names||Protein RIC-3, Resistant to inhibitor of cholinesterase 3, RIC3|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Promotes functional expression of homomeric alpha-7 and alpha-8 nicotinic acetylcholine receptors at the cell surface. May also promote functional expression of homomeric serotoninergic 5- HT3 receptors, and of heteromeric acetylcholine receptors alpha- 3/beta-2, alpha-3/beta-4, alpha-4/beta-2 and alpha-4/beta-4.|
|Cellular Location||Isoform 1: Endoplasmic reticulum membrane; Single-pass membrane protein|
|Tissue Location||Broadly expressed, with high levels in muscle, brain, heart, pancreas and testis. In the central nervous system, highest levels are detected in the cerebellum and pituitary gland Over-expressed in brains from patients with bipolar disease or schizophrenia. Isoform 5 is predominantly expressed in the brain|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
RIC3 is a protein associated with nicotinic acetylcholinereceptors (nAChRs), neurotransmitter-gated ion channels expressedat the neuromuscular junction and within the central and peripheralnervous systems, that can enhance functional expression of multiplenAChR subtypes (Lansdell et al., 2005 [PubMed 16120769]).[suppliedby OMIM].
Walstab, J., et al. J. Biol. Chem. 285(35):26956-26965(2010)Bailey, S.D., et al. Diabetes Care (2010) In press :Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009)Seredenina, T., et al. Biosci. Rep. 28(6):299-306(2008)Roncarati, R., et al. Assay Drug Dev Technol 6(2):181-193(2008)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.